These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9545268)
1. Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor. Lopez-Ilasaca M; Schiene C; Küllertz G; Tradler T; Fischer G; Wetzker R J Biol Chem; 1998 Apr; 273(16):9430-4. PubMed ID: 9545268 [TBL] [Abstract][Full Text] [Related]
2. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506. Shirakata Y; Kobayashi M; Ohtsuka K; Sugano M; Terajima H; Ikai I; Okajima H; Egawa H; Inomata Y; Inamoto T Transplantation; 1995 Dec; 60(12):1582-7. PubMed ID: 8545894 [TBL] [Abstract][Full Text] [Related]
4. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Bell A; Wernli B; Franklin RM Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696 [TBL] [Abstract][Full Text] [Related]
5. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. Endrich MM; Gehring H Eur J Biochem; 1998 Mar; 252(3):441-6. PubMed ID: 9546659 [TBL] [Abstract][Full Text] [Related]
6. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells. Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090 [TBL] [Abstract][Full Text] [Related]
7. Asymmetrical blockade of the Ca2+ release channel (ryanodine receptor) by 12-kDa FK506 binding protein. Chen SR; Zhang L; MacLennan DH Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11953-7. PubMed ID: 7527548 [TBL] [Abstract][Full Text] [Related]
8. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes. Salowe SP; Hermes JD Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023 [TBL] [Abstract][Full Text] [Related]
9. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Kaye RE; Fruman DA; Bierer BE; Albers MW; Zydowsky LD; Ho SI; Jin YJ; Castells MC; Schreiber SL; Walsh CT Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8542-6. PubMed ID: 1382293 [TBL] [Abstract][Full Text] [Related]
10. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). Itoh S; Navia MA Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622 [TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. Jin YJ; Burakoff SJ; Bierer BE J Biol Chem; 1992 Jun; 267(16):10942-5. PubMed ID: 1375932 [TBL] [Abstract][Full Text] [Related]
12. Comparative mutational analysis of peptidyl prolyl cis/trans isomerases: active sites of Escherichia coli trigger factor and human FKBP12. Tradler T; Stoller G; Rücknagel KP; Schierhorn A; Rahfeld JU; Fischer G FEBS Lett; 1997 Apr; 407(2):184-90. PubMed ID: 9166896 [TBL] [Abstract][Full Text] [Related]
13. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells. Fruman DA; Bierer BE; Benes JE; Burakoff SJ; Austen KF; Katz HR J Immunol; 1995 Feb; 154(4):1846-51. PubMed ID: 7530743 [TBL] [Abstract][Full Text] [Related]
14. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth. Song WX; Vacca MF; Welti R; Rintoul DA J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342 [TBL] [Abstract][Full Text] [Related]
15. Suppression of EGFR autophosphorylation by FKBP12. Mathea S; Li S; Schierhorn A; Jahreis G; Schiene-Fischer C Biochemistry; 2011 Dec; 50(50):10844-50. PubMed ID: 22103444 [TBL] [Abstract][Full Text] [Related]
16. Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae. Dolinski K; Scholz C; Muir RS; Rospert S; Schmid FX; Cardenas ME; Heitman J Mol Biol Cell; 1997 Nov; 8(11):2267-80. PubMed ID: 9362068 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits protein kinase C activity and stimulates Na+ transport in A6 cells. Rokaw MD; West M; Johnson JP J Biol Chem; 1996 Dec; 271(50):32468-73. PubMed ID: 8943313 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity. Khattab A; Pica-Mattoccia L; Klinkert MQ; Wenger R; Cioli D Exp Parasitol; 1998 Sep; 90(1):103-9. PubMed ID: 9709036 [TBL] [Abstract][Full Text] [Related]
19. FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex. Futer O; DeCenzo MT; Aldape RA; Livingston DJ J Biol Chem; 1995 Aug; 270(32):18935-40. PubMed ID: 7642551 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo. Okadome T; Oeda E; Saitoh M; Ichijo H; Moses HL; Miyazono K; Kawabata M J Biol Chem; 1996 Sep; 271(36):21687-90. PubMed ID: 8702959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]